News results: "Tarceva" |
|
 |
|
According to an international Phase III clinical trial, led by researchers at The University of...
|
Genentech’s cancer drug Avastin was linked
to a significantly increased risk of blood clots in the...
|
Tarceva’s manufacturers, Genetech Inc and OSI Pharmaceuticals, said the drug proved its...
|
The drug Tarceva, made by OSI Pharmaceuticals has been found to cause an increase in survival rates...
|
After a study disclosed that the drug Tarceva was efficient in prolonging lung cancer survival when...
|
Shares of OSI Pharmaceutical rose $5.25, or 15 percent, to $40.65 at 4 p.m. New York time in Nasdaq...
|
Genentech Inc. and Biogen Idec Inc.
announced that their drug Rituxan combined with chemotherapy...
|
According to the results of a late-stage clinical
trial into the benefits of combining Genentech’s...
|
Genentech Inc. and OSI Pharmaceuticals Inc., two leading biotechnology companies, announced Monday...
|
|
|
|
Shares of OSI Pharmaceutical rose $5.25, or 15 percent, to $40.65 at 4 p.m. New York time in Nasdaq...
|
|
|
|
Lung cancer drug Tarceva jointly developed by OSI
Pharmaceuticals Inc., Genentech Inc. and Roche...
|
The National Human Genome Research Institute is losing one
of its prestigious researchers in the...
|
|
|
|
| Photos Gallery |
|
|
|
|
